Complete Filing Data
INTELLIGENT BIO SOLUTIONS INC. reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $3.69 million for FY2023.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean INTELLIGENT BIO SOLUTIONS INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$10.6M | -$10.2M | -$10.6M | -$8.3M | -$7.0M | -$3.2M |
| Revenue * | $3.1M | $3.1M | $1.3M | $437.1K | $2.0M | $188.7K |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $384.7K | -$137.1K | $212.6K | -$126.9K | -$297.3K | -$147.1K |
| Operating Income Loss | -$10.6M | -$10.3M | -$12.6M | -$8.3M | -$5.6M | -$2.9M |
| Operating Expenses | $12.7M | $12.1M | $13.7M | $8.8M | $7.6M | $3.0M |
| Nonoperating Income Expense | $39.7K | $92.2K | $1.9M | $2.9K | -$1.5M | -$336.0K |
| Net Income Loss Attributable To Noncontrolling Interest | -$36.2K | -$34.2K | -$32.8K | -$27.9K | -$22.9K | -$29.2K |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $384.7K | -$137.1K | $212.6K | -$126.9K | -$297.3K | -$147.1K |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$10.2M | -$10.3M | -$10.5M | -$8.5M | -$7.4M | -$3.3M |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$36.2K | -$34.2K | -$32.8K | -$27.9K | -$22.9K | -$29.2K |
| Comprehensive Income Net Of Tax | -$10.2M | -$10.3M | -$10.4M | -$8.4M | -$7.3M | -$3.3M |
| General And Administrative Expense | $8.9M | $9.3M | $8.0M | $4.9M | $3.4M | $2.2M |
| Interest Expense Other | $167.1K | $223.5K | $7.5K | $1.1M | $457.7K | |
| Research And Development Tax Incentive Receivable Current | $525.3K | $498.8K | $353.0K | $1.0M | ||
| Gross Profit | $1.2M | $1.4M | $326.7K | |||
| Cost Of Revenue | $1.8M | $1.7M | $930.2K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$2.7M | -$3.0M | -$2.5M | -$2.2M | -$2.7M | -$3.0M | -$2.0M | -$2.4M | -$6.3M | -$420.6K | -$1.2M | -$1.3M | -$3.5M | -$1.4M | -$3.1M | -$2.0M | -$1.1M | -$1.8M | -$112.6K | -$1.8M | -$764.8K | |
| Revenue * | $896.8K | $1.1M | $728.9K | $607.5K | $872.3K | $823.8K | $764.1K | $796.1K | $457.1K | $356.7K | $311.3K | $192.5K | $177.8K | $34.3K | $283.0K | $55.4K | -$1.5K | -$798.00 | ||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $13.1K | $48.7K | $116.0K | -$143.2K | $216.4K | -$144.0K | $75.1K | -$18.0K | -$77.8K | $361.6K | -$135.6K | $2.8K | $7.4K | -$67.5K | -$262.0K | $33.9K | -$50.6K | $100.9K | -$133.3K | $4.2K | ||
| Operating Income Loss | -$2.6M | -$3.0M | -$2.6M | -$2.3M | -$2.7M | -$3.0M | -$2.0M | -$2.5M | -$6.5M | -$2.1M | -$1.2M | -$1.3M | -$3.5M | -$1.4M | -$3.1M | -$917.3K | -$663.0K | -$28.8K | -$1.7M | |||
| Operating Expenses | $3.2M | $3.7M | $3.1M | $2.6M | $3.2M | $3.2M | $2.3M | $2.9M | $6.7M | $2.6M | $1.5M | $1.5M | $3.6M | $1.4M | $3.2M | $1.2M | $718.4K | $27.3K | $1.7M | |||
| Nonoperating Income Expense | -$50.9K | $4.6K | $2.6K | $7.7K | $30.5K | -$33.0K | $15.0K | $93.9K | $191.4K | $1.7M | $4.3K | -$1.3K | $2.8K | $1.5K | -$2.2K | -$1.1M | -$413.9K | -$82.3K | -$149.1K | |||
| Net Income Loss Attributable To Noncontrolling Interest | -$9.0K | -$12.0K | -$7.1K | -$7.3K | -$9.2K | -$9.1K | -$6.7K | -$7.2K | -$8.1K | -$6.5K | -$5.8K | -$8.9K | -$3.8K | -$5.2K | -$14.9K | -$6.4K | -$4.4K | $1.5K | -$16.7K | |||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $13.1K | $48.7K | $116.0K | -$143.2K | $216.4K | -$144.0K | $75.1K | -$18.0K | -$77.8K | $361.6K | -$135.6K | $2.8K | $7.4K | -$67.5K | -$262.0K | $33.9K | -$50.6K | |||||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$2.7M | -$2.9M | -$2.4M | -$2.4M | -$2.5M | -$3.1M | -$1.9M | -$2.5M | -$6.4M | -$65.5K | -$1.3M | -$1.3M | -$3.5M | -$1.5M | -$3.4M | -$2.0M | -$1.1M | |||||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$9.0K | -$12.0K | -$7.1K | -$7.3K | -$9.2K | -$9.1K | -$6.7K | -$7.2K | -$8.1K | -$6.5K | -$5.8K | -$8.9K | -$3.8K | -$5.2K | -$14.9K | -$6.4K | -$4.4K | |||||
| Comprehensive Income Net Of Tax | -$2.7M | -$2.9M | -$2.4M | -$2.4M | -$2.5M | -$3.1M | -$1.9M | -$2.4M | -$6.4M | -$59.0K | -$1.3M | -$1.3M | -$3.5M | -$1.5M | -$3.4M | -$2.0M | -$1.1M | |||||
| General And Administrative Expense | $2.7M | $2.4M | $1.8M | $1.9M | $2.4M | $1.7M | $2.5M | $1.9M | $2.2M | $1.5M | $1.1M | $1.0M | $1.3M | $1.0M | $671.5K | $521.0K | $53.8K | $972.0K | ||||
| Interest Expense Other | $42.7K | $32.5K | $37.4K | $86.1K | $76.8K | $1.1K | $4.2K | $675.00 | $18.6K | $986.9K | $85.8K | $82.3K | $149.1K | |||||||||
| Research And Development Tax Incentive Receivable Current | $505.2K | $924.1K | $734.4K | $520.3K | $375.7K | $648.3K | $332.5K | $289.2K | $559.6K | $578.5K | $490.6K | $571.9K | $181.6K | $1.1M | $982.9K | |||||||
| Gross Profit | $459.7K | $518.3K | $341.4K | $223.1K | $346.8K | $178.5K | $199.2K | $232.3K | $33.0K | $244.0K | ||||||||||||
| Cost Of Revenue | $437.0K | $593.5K | $387.5K | $384.4K | $525.5K | $645.3K | $564.8K | $563.8K | $424.0K | $112.6K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $8.3M | $3.8M | $6.6M | $15.1M | -$5.2M | -$4.0M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $1.5M | $8.2M | $12.6M | $427.3K | $197.9K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$5.3M | $4.8M | -$6.7M | -$4.3M | $12.1M | $229.3K | |
| Retained Earnings Accumulated Deficit | -$52.0M | -$41.8M | -$31.2M | -$22.9M | -$15.8M | ||
| Other Assets Current | $497.6K | $552.8K | $746.8K | $2.5M | $49.1K | ||
| Minority Interest | -$146.2K | -$112.0K | -$79.2K | -$51.2K | -$28.3K | ||
| Liabilities Current | $5.5M | $5.9M | $4.7M | $3.7M | $7.7M | ||
| Liabilities And Stockholders Equity | $13.8M | $10.4M | $12.4M | $21.9M | $2.5M | ||
| Liabilities | $5.6M | $6.7M | $5.8M | $6.9M | $7.7M | ||
| Cash And Cash Equivalents At Carrying Value | $6.3M | $1.5M | $8.2M | $12.6M | $427.3K | ||
| Assets Current | $8.5M | $3.9M | $10.9M | $18.2M | $2.3M | ||
| Assets | $13.8M | $10.4M | $12.4M | $21.9M | $2.5M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$712.6K | -$575.5K | -$788.1K | -$661.3K | -$364.0K | ||
| Accounts Payable And Accrued Liabilities Current | $1.7M | $2.6M | $1.6M | $1.5M | $787.5K | ||
| Employee Related Liabilities Noncurrent | $63.6K | $24.9K | $50.6K | $21.8K | |||
| Common Stock Value | $34.6K | $1.9K | $7.4K | $135.8K | $86.3K | ||
| Employee Related Liabilities Current | $469.4K | $358.9K | $201.3K | $102.5K | |||
| Deferred Income Current | $2.5M | $2.3M | $2.8M | $2.1M | |||
| Property Plant And Equipment Net | $565.9K | $690.2K | $391.4K | ||||
| Treasury Stock Common Shares | 116.00 | 116.00 | 0.00 | ||||
| Treasury Stock Value | $1.00 | $1.00 | |||||
| Notes Payable Current | $515.3K | $353.2K | |||||
| Inventory Net | $777.5K | $979.9K | |||||
| Intangible Assets Net Excluding Goodwill | $4.4M | $5.3M | |||||
| Accounts Receivable Net Current | $429.7K | $293.9K | |||||
| Finance Lease Right Of Use Asset Amortization | $243.6K | $238.7K | $152.3K | ||||
| Equity Securities Fv Ni Gain Loss | $175.7K | $2.2M | |||||
| Operating Lease Right Of Use Asset | $306.7K | $546.5K | |||||
| Operating Lease Liability Current | $274.8K | $223.4K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $11.1M | $3.6M | $3.0M | $5.1M | $4.4M | $6.1M | $8.2M | $11.1M | $3.3M | $1.4M | $6.0M | $10.4M | $5.3M | $8.8M | $10.1M | $13.6M | $15.9M | $18.8M | -$3.0M | -$5.9M | -$5.9M | -$3.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $740.4K | $1.7M | $1.0M | $2.8M | $2.2M | $4.0M | $6.3M | $9.4M | $1.1M | $186.4K | $2.3M | $2.9M | $5.7M | $10.8M | $11.2M | $12.6M | $14.3M | $19.9M | $994.2K | $18.1K | $255.3K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $640.2K | -$2.3M | -$1.4M | -$2.5M | $34.8K | $566.9K | ||||||||||||||||
| Retained Earnings Accumulated Deficit | -$68.2M | -$65.5M | -$62.5M | -$59.4M | -$56.9M | -$54.6M | -$49.2M | -$46.2M | -$44.2M | -$39.1M | -$32.8M | -$32.4M | -$29.1M | -$27.8M | -$24.3M | -$22.0M | -$18.9M | |||||
| Other Assets Current | $480.1K | $488.2K | $827.0K | $585.5K | $348.7K | $396.2K | $481.0K | $331.6K | $413.3K | $531.8K | $521.9K | $148.9K | $266.2K | $148.2K | $2.3M | $2.3M | $88.5K | |||||
| Minority Interest | -$203.3K | -$194.3K | -$182.3K | -$169.8K | -$162.7K | -$155.3K | -$135.0K | -$125.9K | -$119.2K | -$99.5K | -$91.4K | -$84.9K | -$69.1K | -$60.2K | -$56.4K | -$54.0K | -$39.1K | |||||
| Liabilities Current | $5.1M | $5.1M | $5.4M | $4.6M | $4.4M | $5.7M | $5.7M | $5.2M | $6.8M | $3.5M | $4.8M | $2.4M | $4.4M | $4.0M | $2.8M | $1.6M | $1.2M | |||||
| Liabilities And Stockholders Equity | $17.7M | $10.0M | $8.2M | $9.6M | $8.7M | $11.7M | $17.0M | $8.8M | $8.7M | $10.7M | $18.0M | $10.2M | $14.4M | $15.2M | $19.1M | $17.5M | $20.0M | |||||
| Liabilities | $6.8M | $6.6M | $5.4M | $4.6M | $4.5M | $5.8M | $6.0M | $5.7M | $7.5M | $4.7M | $7.8M | $5.0M | $5.7M | $5.2M | $5.6M | $1.6M | $1.2M | |||||
| Cash And Cash Equivalents At Carrying Value | $740.4K | $1.7M | $1.0M | $2.8M | $2.2M | $4.0M | $9.4M | $1.1M | $186.4K | $2.3M | $2.9M | $5.7M | $10.8M | $11.2M | $12.6M | $14.3M | $19.9M | |||||
| Assets Current | $12.2M | $4.5M | $4.1M | $5.1M | $4.1M | $6.5M | $11.5M | $2.9M | $2.7M | $4.4M | $6.4M | $8.2M | $12.9M | $14.1M | $15.9M | $16.6M | $20.0M | |||||
| Assets | $17.7M | $10.0M | $8.2M | $9.6M | $8.7M | $11.7M | $17.0M | $8.8M | $8.7M | $10.7M | $18.0M | $10.2M | $14.4M | $15.2M | $19.1M | $17.5M | $20.0M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$266.1K | -$279.2K | -$327.9K | -$523.4K | -$639.4K | -$496.3K | -$662.4K | -$518.4K | -$593.5K | -$639.9K | -$562.1K | -$923.7K | -$718.6K | -$721.4K | -$728.7K | -$642.7K | -$380.7K | |||||
| Accounts Payable And Accrued Liabilities Current | $4.3M | $4.0M | $4.5M | $1.3M | $1.1M | $1.8M | $2.1M | $1.8M | $3.6M | $1.6M | $1.9M | $1.0M | $884.3K | $448.9K | $808.7K | $1.5M | $734.8K | |||||
| Employee Related Liabilities Noncurrent | $106.9K | $100.0K | $84.9K | $72.7K | $63.3K | $69.7K | $30.3K | $30.0K | $27.7K | $24.9K | $23.7K | $20.8K | $36.5K | $30.7K | $30.3K | $18.1K | $17.9K | |||||
| Common Stock Value | $12.4K | $91.0K | $7.3K | $67.9K | $48.1K | $43.8K | $29.1K | $14.8K | $23.3K | $16.9K | $9.2K | $148.9K | $148.9K | $148.8K | $148.8K | $118.8K | $104.2K | |||||
| Employee Related Liabilities Current | $470.5K | $567.1K | $535.0K | $447.7K | $416.9K | $477.5K | $660.0K | $366.9K | $407.0K | $334.2K | $319.1K | $299.7K | $171.3K | $129.2K | $126.1K | |||||||
| Deferred Income Current | $2.3M | $2.3M | $2.6M | $2.3M | $2.4M | $2.2M | $1.1M | $2.2M | $3.4M | $3.4M | $1.8M | |||||||||||
| Property Plant And Equipment Net | $321.7K | $271.7K | $251.3K | $546.5K | $537.2K | $586.1K | $559.5K | $591.3K | $664.9K | $478.1K | $484.3K | $416.0K | ||||||||||
| Treasury Stock Common Shares | 12.00 | 116.00 | 12.00 | 116.00 | 116.00 | 116.00 | 116.00 | 116.00 | 1.4K | 1.4K | ||||||||||||
| Treasury Stock Value | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | $14.00 | $14.00 | $14.00 | |||||||||||
| Notes Payable Current | $13.0K | $139.8K | $197.1K | $356.2K | $405.5K | $499.6K | $368.5K | $370.5K | $341.8K | $335.5K | $326.0K | |||||||||||
| Inventory Net | $590.2K | $628.2K | $635.2K | $683.5K | $701.3K | $738.8K | $877.9K | $942.1K | $965.1K | $736.2K | $671.0K | |||||||||||
| Intangible Assets Net Excluding Goodwill | $3.3M | $3.5M | $3.8M | $3.8M | $3.9M | $4.4M | $4.6M | $4.9M | $4.9M | $5.3M | $5.5M | |||||||||||
| Accounts Receivable Net Current | $456.7K | $717.8K | $594.6K | $511.0K | $266.1K | $578.6K | $431.6K | $262.8K | $567.5K | $296.0K | $278.3K | |||||||||||
| Finance Lease Right Of Use Asset Amortization | $45.5K | $61.5K | $60.0K | $45.5K | $48.6K | |||||||||||||||||
| Equity Securities Fv Ni Gain Loss | $44.5K | $131.3K | $269.8K | $1.8M | ||||||||||||||||||
| Operating Lease Right Of Use Asset | $1.9M | $1.8M | $69.5K | $126.8K | $182.6K | $260.8K | $365.5K | $432.7K | $471.5K | |||||||||||||
| Operating Lease Liability Current | $382.5K | $362.8K | $84.7K | $151.3K | $205.9K | $281.6K | $260.4K | $250.8K | $227.4K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$9.7M | -$9.6M | -$7.4M | -$3.4M | -$11.3M | -$498.6K |
| Increase Decrease In Other Current Assets | $329.4K | -$55.2K | $118.3K | $333.7K | $2.5M | -$99.3K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $27.2K | -$707.00 | -$64.9K | -$97.1K | $40.0K | $8.1K |
| Increase Decrease In Research And Development Tax Incentive Receivable | $209.1K | $26.6K | $145.7K | -$672.4K | $1.0M | |
| Increase Decrease In Other Accounts Payable | -$633.0K | $84.5K | $256.0K | $783.0K | ||
| Net Cash Provided By Used In Financing Activities | $4.6M | $14.6M | $1.4M | $23.4M | $733.9K | |
| Net Cash Provided By Used In Investing Activities | -$231.8K | -$221.4K | -$694.1K | -$880.2K | -$14.0K | |
| Share Based Compensation | $238.0K | $230.5K | $260.0K | |||
| Increase Decrease In Accounts Receivable | $164.9K | $135.8K | $293.9K | -$1.8M | ||
| Increase Decrease In Other Noncurrent Liabilities | $21.3K | -$364.1K | $28.9K | $21.8K | ||
| Increase Decrease In Inventories | -$142.3K | -$202.4K | $345.4K | |||
| Depreciation Depletion And Amortization | $970.1K | $974.4K | $814.5K | |||
| Increase Decrease In Grant Receivable And Deferred Grant Income | $2.5M | -$148.6K | -$1.0M | -$1.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q3 2024 | Q1 2024 | Q3 2023 | Q4 2022 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$2.8M | -$2.4M | -$1.3M | -$1.9M | $83.0K | -$2.7M | ||
| Increase Decrease In Other Current Assets | -$338.8K | -$101.4K | -$139.5K | $207.1K | -$240.2K | -$705.00 | ||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -$743.00 | $30.1K | -$39.0K | -$127.0K | -$48.2K | -$50.6K | ||
| Increase Decrease In Research And Development Tax Incentive Receivable | $189.7K | $123.0K | $60.8K | $218.8K | ||||
| Increase Decrease In Other Accounts Payable | $221.3K | $1.2M | -$13.3K | -$635.6K | ||||
| Net Cash Provided By Used In Financing Activities | $3.6M | $42.5K | $3.3M | |||||
| Net Cash Provided By Used In Investing Activities | -$70.4K | -$474.9K | ||||||
| Share Based Compensation | $12.0K | $202.0K | $218.3K | $260.0K | ||||
| Increase Decrease In Accounts Receivable | $123.2K | $148.9K | $273.6K | -$147.3K | -$2.5M | |||
| Increase Decrease In Other Noncurrent Liabilities | $15.1K | $6.1K | -$29.8K | $8.5K | $15.6K | |||
| Increase Decrease In Inventories | -$7.0K | -$38.7K | $53.0K | |||||
| Depreciation Depletion And Amortization | $257.9K | $241.6K | $247.6K | |||||
| Increase Decrease In Grant Receivable And Deferred Grant Income | $97.1K | $177.5K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$2.00 | -$6.38 | -$127.00 | -$11.33 | -$0.68 | -$0.37 |
| Earnings Per Share Basic | $-2.00 | $-6.38 | $-127.00 | $-11.33 | $-0.68 | |
| Weighted Average Number Of Shares Outstanding Basic | 5.3M | 1.6M | 83.7K | 733.3K | 10.4M | |
| Common Stock Shares Outstanding | 3.5M | 194.2K | 13.6M | 8.6M | ||
| Common Stock Shares Issued | 3.5M | 194.2K | 744.5K | 13.6M | 8.6M | |
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | ||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | ||
| Weighted Average Number Of Diluted Shares Outstanding | 5.3M | 1.6M | 83.7K | 733.3K | ||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q1 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$2.82 | -$0.35 | -$0.44 | -$4.96 | -$0.70 | -$1.43 | -$2.07 | -$12.48 | -$68.67 | -$5.56 | -$1.62 | -$0.23 | -$0.10 | -$0.27 | -$0.23 | -$0.12 | -$0.01 | -$0.22 | ||||
| Earnings Per Share Basic | $-2.82 | $-0.35 | $-0.44 | $-4.96 | $-0.70 | $-1.43 | $-2.07 | $-12.48 | $-68.67 | $-5.56 | $-1.62 | $-1.79 | $-4.65 | $-0.10 | $-0.27 | |||||||
| Weighted Average Number Of Shares Outstanding Basic | 950.8K | 8.5M | 5.8M | 453.6K | 3.8M | 2.1M | 949.7K | 194.2K | 92.4K | 75.7K | 14.9M | 744.5K | 744.1K | 14.0M | 11.8M | |||||||
| Common Stock Shares Outstanding | 1.2M | 9.1M | 732.3K | 6.8M | 4.8M | 4.4M | 2.9M | 1.5M | 2.3M | 1.7M | 917.7K | 14.9M | 744.5K | 14.9M | 14.9M | 14.9M | 11.9M | 10.4M | ||||
| Common Stock Shares Issued | 1.2M | 9.1M | 732.3K | 6.8M | 4.8M | 4.4M | 2.9M | 1.5M | 2.3M | 1.7M | 917.7K | 14.9M | 14.9M | 14.9M | 14.9M | 11.9M | 10.4M | |||||
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | |||||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 950.8K | 8.5M | 5.8M | 453.6K | 3.8M | 2.1M | 949.7K | 194.2K | 92.4K | 75.7K | 744.5K | |||||||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||||||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Development And Regulatory Approval Expenses | $2.4M | $1.7M | $507.4K | $3.9M | $3.8M | $588.2K |
| Foreign Currency Transaction Gain Loss Realized | -$911.00 | -$1.2K | -$9.8K | -$4.0K | -$271.2K | |
| Interest And Other Income | $84.8K | $9.7K | $14.4K | $13.8K | $97.00 | |
| Government Support Income | $424.8K | $737.6K | $437.1K | $2.0M | $69.8K | |
| Additional Paid In Capital | $61.0M | $46.2M | $38.6M | $38.4M | $10.9M | |
| Noncash Other Operating Activities | -$113.6K | $24.2K | $94.3K | $8.2K | $66.1K | $36.0K |
| Depreciation And Amortization | $1.2M | $1.2M | $966.7K | |||
| Conversion Of Preferred Shares Into Common Shares | 57.3K | 36.9K | 13.0K | 45.1K | ||
| Stock Issued During Period Value New Issues | $4.6M | $162.5K | $21.6M | |||
| Stock Issued During Period Value Other | $3.8M | $2.1M | $3.3M | $2.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Development And Regulatory Approval Expenses | $522.1K | $486.2K | $358.4K | $506.9K | $948.8K | $471.3K | $348.5K | $103.9K | $299.9K | $1.2K | $79.3K | $413.3K | $2.6M | $106.8K | $2.2M | $341.8K | $30.9K | -$58.8K | |||
| Foreign Currency Transaction Gain Loss Realized | -$113.00 | -$750.00 | -$51.00 | -$996.00 | -$555.00 | $7.2K | -$13.9K | -$2.2K | $10.00 | $14.00 | -$3.1K | $8.8K | -$86.6K | -$192.5K | |||||||
| Interest And Other Income | $10.6K | $3.5K | $139.00 | $508.00 | $1.5K | $7.6K | $2.9K | $3.5K | $4.6K | $7.6K | $434.00 | $70.00 | $22.00 | $27.00 | |||||||
| Government Support Income | $83.8K | $153.2K | $109.9K | $117.7K | $269.6K | $311.3K | $192.5K | $177.8K | $34.3K | $283.0K | $55.4K | ||||||||||
| Additional Paid In Capital | $79.5M | $69.3M | $65.8M | $65.0M | $61.9M | $61.2M | $60.9M | $50.0M | $46.2M | $45.8M | $43.7M | $38.4M | $38.4M | $38.4M | $38.4M | $38.4M | $38.0M | ||||
| Noncash Other Operating Activities | -$147.8K | $33.2K | -$104.5K | -$25.0K | -$20.1K | ||||||||||||||||
| Depreciation And Amortization | $281.9K | $303.4K | $302.0K | $305.2K | $300.4K | $318.9K | $290.3K | $307.6K | $399.0K | $398.2K | |||||||||||
| Conversion Of Preferred Shares Into Common Shares | 13.0K | ||||||||||||||||||||
| Stock Issued During Period Value New Issues | $8.9M | $3.2M | $642.1K | $34.5K | $162.5K | $21.6M | |||||||||||||||
| Stock Issued During Period Value Other | $12.0K | $1.7M | $3.8M | $2.1M | $3.3M | $1.9M |
Most recent annual filing with the SEC: August 15, 2025
Data sourced from SEC EDGAR public filings as of August 4, 2026.